von Autenried Paul
SEC CIK 1524143 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol Myers Squibb | EVP, CIO | 80.9K | — | $4.63M | 4 | 2021-07-30 | 2021-11-22 |
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
von Autenried Paul made no open-market trades at BMY in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-11-24 | 2021-11-22+ | BMY | Bristol Myers Squibb | von Autenried Paul | EVP, CIO | S - Sale | $57.18 | -51.1K | 80.9K | -39% | -$2.92M |
| I | 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | von Autenried Paul | EVP, CIO | G - Gift | $0.00 | +114.7K | 114.7K | New | $0 |
| 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | von Autenried Paul | EVP, CIO | G - Gift | $0.00 | -114.7K | 0 | -100% | $0 | |
| 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | von Autenried Paul | EVP, CIO | S - Sale | $68.06 | -25.0K | 114.7K | -18% | -$1.70M |
Purchase Sale Sale after option exercise All abbreviations